Where can I learn more about this study?
You can find more information about this study on the websites listed below. When a full report of the study results is available, it can also be found here.

- www.clinicaltrials.gov Once you are on the website, type "NCT04641299" into the search box and click "Search".
- www.clinicaltrialsregister.eu Once you are on the website, click "Home and Search", then type "2020-000767-23" in the search box and click "Search".
- www.AstraZenecaClinicalTrials.com Once you are on the website, type "D7990C00003" into the search box and click "Find a Study".

Full Study Title: A Randomized, Parallel, Double-blind, Placebo-controlled, Dose-ranging, Phase 2b Study to Evaluate the Efficacy, Safety and Tolerability of AZD8233 Treatment in Participants with Dyslipidemia
AstraZeneca Protocol Number: D7990C00003
National Clinical Trials Number: NCT04641299
EudraCT Number: 2020-000767-23

AstraZeneca AB sponsored this study and has its headquarters in Södertälje, Sweden

The phone number for the AstraZeneca Information Center is +1-877-240-9479.

Thank you!

Clinical study participants belong to a large community of people who take part in clinical research around the world. They help researchers answer important health questions and find medical treatments for patients.

The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants for clinical studies, nor is it involved in conducting clinical studies.

CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org